Stocks and Investing
Stocks and Investing
Wed, November 3, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
John Walsh Maintained (XYL) at Sell with Increased Target to $111 on, Nov 3rd, 2021
John Walsh of Credit Suisse, Maintained "Xylem Inc." (XYL) at Sell with Increased Target from $105 to $111 on, Nov 3rd, 2021.
John has made no other calls on XYL in the last 4 months.
There are 2 other peers that have a rating on XYL. Out of the 2 peers that are also analyzing XYL, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Scott Graham of "Rosenblatt" Downgraded from Strong Buy to Hold and Decreased Target to $120 on, Friday, October 1st, 2021
This is the rating of the analyst that currently disagrees with John
- Deane Dray of "RBC Capital" Maintained at Buy with Decreased Target to $136 on, Friday, October 1st, 2021
Contributing Sources